Some approaches for creating of pharmacologically active polymer derivatives of medicines with antitumor activity


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article describes the main problems associated with currently used anticancer chemotherapy. The main groups of cytotoxic drugs and details of their mechanism of action are presented. General concepts of promising modern method of anticancer therapy, an application of polymer derivatives of medicines, are explained. Polymeric compounds can alter the pharmacokinetics of drugs and increase their blood circulation time due to high molecular weight. This improves the efficiency of the capture of polymeric derivatives by tumor cells, which are characterized by increased endocytosis in contrast to normal cells. The characteristics of polymers (polycations, polyanions and neutral polymers) used for the transport systems of selective drug delivery are discussed. The features of the development of micellar delivery systems and vaccination type systems represented by the classical Ringsdorf model are determined.

Full Text

Restricted Access

References

  1. Состояние онкологической помощи населению России в 2010 г. / Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М., 2011. 188 с.
  2. Онкология. Национальное руководство / Под ред. В.И. Чиссова, М.И. Давыдова. М., 2008. 1072 с.
  3. Абазурова Г.Р., Алексеев Б.Я. Онкология. Клинические рекомендации / Под ред. B.И. Чиссова. 2-е изд. М., 2009. 928 с.
  4. Государственный реестр лекарственных средств МЗ РФ, М., 2002.
  5. Харкевич Д.А. Фармакология. 10-е изд. М., 2010. 752 с.
  6. Корман Д.Б. Основы противоопухолевой химиотерапии. Практическая медицина. М., 2006. 512 с.
  7. Вельшер Л.З., Поляков Б.И., Петерсон С.Б. Клиническая онкология. Избранные лекции. М., 2009. 148 с.
  8. Проценко С.А. Поиски путей индивидуализации противоопухолевой терапии // Практическая онкология 2007. № 8. C. 175-181.
  9. Gabizon A.A. Liposomal Drug Carriers in Cancer Therapy. In Torchilin V.P., ed. Nanoparticulates as Drug Carriers. London: Imperiae Colledge Press, 2006:437-62.
  10. Платэ Н.А., Васильев А.Е. Физиологически активные полимеры. М., 1986. 296 с.
  11. Elvira C., Gallardo A., Roman S.J., Cifuentes A. Covalent Polymer Drug Conjugates. Molecules 2005;10:114-25.
  12. Kim J.O., Nukolova N.V., Oberoi H.S,. Kabanov A.V., Bronich T.K. Block ionomer complex micelles with cross-linked cores for drug delivery. Polym Sci Ser A Chem Phys 2009;51(6):708-18.
  13. Bae Y., Diezi T.A., Zhao A., Kwon G.S. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents. J Contr Rel 2007;122:324-30.
  14. Adams M.L., Lavasanifar A., Kwon G.S. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003;92:1343-55.
  15. Gaucher G., Marchessault R.H., Leroux J.C. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Contr Rel 2010;143(1):2-12.
  16. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006;112(3):630-48.
  17. Danquah M., Li F., Duke C.B., Miller D.D., Mahato R.I. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res
  18. Sosnik A., Carcaboso A.M., Chappetta D.A. Polymeric nanocarriers: new endeavors for the optimization of the thechnological aspects of drugs. Resent Patents on Biomedical Engineering 2008;1:43-59.
  19. Kim J.Y., Kim S., Pinal R., Park K. Hydrotropic polymer micelles as vehicles for delivery of poorly water-soluble drugs. J Contr Rel 2011;1:1320.
  20. Huh K.M., Lee S.C., Cho Y.W., et al. Hydrotropic polymer micelles system. J Contr Rel 2005;101:59-68.
  21. Li F., Danquah M., Mahato R.I. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery. Biomolecules 2010;11:2610-20.
  22. Adams M.L., Lavasanifar A., Kwon G.S. Amphiphulic block copolymers for drug delivery. J Pharm Sci 2003;92(7):1343-55.
  23. Mourya V.K., Inamdar N., Nawale R.B., Kulthe S.S. Polymeric micelles: general consideration and their applications. Ind J Pharm Edu Res 2011;45(2):120-38.
  24. Rangel-Yagui C.O., Pessoa A., Tavares L.C. Micellar solubilization of drugs. J Pharm Sci 2005;8(2):147-63.
  25. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006;6(9):
  26. Li C, Wallace S. Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev 2008;60(8):886-98.
  27. Vicent M.J., Duncan R. Polymer therapeutics: clinical applications and challenges for development. Adv Drug Deliv Rev 2009;61(13):1117-20.
  28. Vicent M.J., Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol 2006;24(1):39-47.
  29. Greco F., Vicent M.J. Polymer-drug conjugates: current status and future trends. Frontiers Biosci 2008;13:2744-56.
  30. Vicent M.J., Dieudonne L., Carbajo R.J., Pineda-Lucena A. Polymer conjugates as therapeutics: future trends, challenges and opportunities. Expert Opin Drug Deliv 2008;5(5):593-614.
  31. Gaspar R., Duncan R. Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics. Adv Drug Deliv Rev 2009;61(12):1220-32.
  32. Lammers T. Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations. Adv Drug Deliv Rev 2010;62(2):203-30.
  33. Greco F., Vicent M.J. Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 2009;61(13):1203-13.
  34. Khandare J., Minko T. Polymer-drug conjugates: progress in polymeric prodrugs. Progr Polym Sci 2006;31(4):359-97.
  35. Lammers T., Ulbrich K. HPMA copolymers: 30 years of advances. Adv Drug Deliv Rev 2009;62(2):119-21.
  36. Ringsdorf H. Structure and properties of pharmacologically active polymers. J Polym Sci 1975;51:135-53.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies